CRNX
Crinetics Pharmaceuticals Inc
85.00$
+0.0%
vs. previous close
Closing price · As of: Sep 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 865.9% | 451.5% | 1,008.2% | 3,479.1% | 80,278.9% | 117.1% | 29.3% | 27.4% | 268.0% | 14.0% | |
| -765.9% | -351.5% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 86.0% | |
| 865.9% | 451.5% | 1,008.2% | 3,479.1% | 80,278.9% | 7,815.9% | 2,749.1% | 4,199.5% | 23,114.1% | 4,314.7% | |
| 260.3% | 94.8% | 274.3% | 1,133.2% | 25,388.7% | 2,275.0% | 895.0% | 1,447.6% | 9,599.3% | 2,486.1% | |
| 1,026.1% | 446.3% | 1,182.5% | 4,512.3% | 105,567.6% | 10,090.9% | 3,644.1% | 5,647.2% | 32,713.5% | 6,800.8% | |
| -1,026.1% | -446.3% | -1,182.5% | -4,512.3% | -105,567.6% | -9,990.9% | -3,544.1% | -5,547.2% | -32,613.5% | -6,714.8% | |
| 1.9% | 0.4% | 0.0% | 0.0% | 1,395.8% | 5.7% | 91.1% | – | – | – | |
| -1,021.9% | -447.8% | -1,116.8% | -4,226.5% | -103,960.6% | -9,985.3% | -3,460.4% | -5,345.9% | -28,720.7% | -6,043.9% | |
| 1.7% | -2.0% | 65.7% | -74.4% | -1,335.2% | -85.5% | -83.7% | 23.2% | – | 2.3% | |
| -1,021.9% | -447.8% | -1,116.8% | -4,152.1% | -102,625.4% | -9,899.7% | -3,376.7% | -5,345.9% | -28,720.7% | -6,046.2% | |
| -1,010.5% | -440.0% | -1,163.1% | -4,438.0% | -104,232.4% | -9,905.4% | -3,523.3% | -5,318.5% | -28,452.6% | -5,993.3% |
Data as of: September 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.